News
News
News
tinniwell app with external in-ears launches in the first quarter of 2026 – DiGA listing planned in Germany
Oct 3, 2025
tinniwell app with external in-ears launches in the first quarter of 2026 – DiGA listing planned in Germany
Oct 3, 2025
tinniwell app with external in-ears launches in the first quarter of 2026 – DiGA listing planned in Germany
Oct 3, 2025
tinniwell® shows breakthrough in migraine therapy
Aug 22, 2025
tinniwell® shows breakthrough in migraine therapy
Aug 22, 2025
tinniwell® shows breakthrough in migraine therapy
Aug 22, 2025
Tinnitus in the Focus of Research:
Jul 23, 2025
Tinnitus in the Focus of Research:
Jul 23, 2025
Tinnitus in the Focus of Research:
Jul 23, 2025
tinniwell use increases by over 900%
Jun 2, 2025
tinniwell use increases by over 900%
Jun 2, 2025
tinniwell use increases by over 900%
Jun 2, 2025
Apple Hearing Study confirms: Tinnitus is widespread
May 5, 2025
Apple Hearing Study confirms: Tinnitus is widespread
May 5, 2025
Apple Hearing Study confirms: Tinnitus is widespread
May 5, 2025
Resaphene reaches an important milestone
Feb 25, 2025
Resaphene reaches an important milestone
Feb 25, 2025
Resaphene reaches an important milestone
Feb 25, 2025
Preparations for the double-blind study are starting
Jan 21, 2025
Preparations for the double-blind study are starting
Jan 21, 2025
Preparations for the double-blind study are starting
Jan 21, 2025
Market entry in India is imminent
Dec 4, 2024
Market entry in India is imminent
Dec 4, 2024
Market entry in India is imminent
Dec 4, 2024
Exclusive distribution contract for tinniwell in Turkey
Sep 25, 2024
Exclusive distribution contract for tinniwell in Turkey
Sep 25, 2024
Exclusive distribution contract for tinniwell in Turkey
Sep 25, 2024
Multiplication of the tinniwell sales
Jun 3, 2024
Multiplication of the tinniwell sales
Jun 3, 2024
Multiplication of the tinniwell sales
Jun 3, 2024
Demand for tinniwell increases monthly by about 10%
Feb 6, 2024
Demand for tinniwell increases monthly by about 10%
Feb 6, 2024
Demand for tinniwell increases monthly by about 10%
Feb 6, 2024
Ninth series of the tinniwell produced for the European market
Jan 25, 2024
Ninth series of the tinniwell produced for the European market
Jan 25, 2024
Ninth series of the tinniwell produced for the European market
Jan 25, 2024
Brain implant for tinnitus is not coming after all
Oct 17, 2023
Brain implant for tinnitus is not coming after all
Oct 17, 2023
Brain implant for tinnitus is not coming after all
Oct 17, 2023
Increasing the linear temperature shows a significant effect
Aug 15, 2023
Increasing the linear temperature shows a significant effect
Aug 15, 2023
Increasing the linear temperature shows a significant effect
Aug 15, 2023
First series of tinniwell produced for the Chinese market
May 9, 2023
First series of tinniwell produced for the Chinese market
May 9, 2023
First series of tinniwell produced for the Chinese market
May 9, 2023
Contract for exclusive distribution of tinniwell in China signed
Apr 2, 2023
Contract for exclusive distribution of tinniwell in China signed
Apr 2, 2023
Contract for exclusive distribution of tinniwell in China signed
Apr 2, 2023
tinniwell is the market leader in tinnitus therapy
Feb 8, 2023
tinniwell is the market leader in tinnitus therapy
Feb 8, 2023
tinniwell is the market leader in tinnitus therapy
Feb 8, 2023
Demand for tinniwell increases by 76%
Nov 7, 2022
Demand for tinniwell increases by 76%
Nov 7, 2022
Demand for tinniwell increases by 76%
Nov 7, 2022
Brain blood flow influences the severity of tinnitus.
Sep 26, 2022
Brain blood flow influences the severity of tinnitus.
Sep 26, 2022
Brain blood flow influences the severity of tinnitus.
Sep 26, 2022
The FDA approval process for the tinnitus therapy tinniwell is continuing.
Jul 13, 2022
The FDA approval process for the tinnitus therapy tinniwell is continuing.
Jul 13, 2022
The FDA approval process for the tinnitus therapy tinniwell is continuing.
Jul 13, 2022
Long COVID multiplies the revenue of tinniwell
May 20, 2022
Long COVID multiplies the revenue of tinniwell
May 20, 2022
Long COVID multiplies the revenue of tinniwell
May 20, 2022
Framework agreement for the delivery of 2,000 pieces of tinniwell concluded
Mar 7, 2022
Framework agreement for the delivery of 2,000 pieces of tinniwell concluded
Mar 7, 2022
Framework agreement for the delivery of 2,000 pieces of tinniwell concluded
Mar 7, 2022
2nd contract manufacturer produces 6th series of the tinniwell
Feb 28, 2022
2nd contract manufacturer produces 6th series of the tinniwell
Feb 28, 2022
2nd contract manufacturer produces 6th series of the tinniwell
Feb 28, 2022
Production capacities are being expanded – tinnitus is a common consequence of a COVID-19 infection
Jan 2, 2022
Production capacities are being expanded – tinnitus is a common consequence of a COVID-19 infection
Jan 2, 2022
Production capacities are being expanded – tinnitus is a common consequence of a COVID-19 infection
Jan 2, 2022
tinniwell shows very good effects in migraine patients
Oct 25, 2021
tinniwell shows very good effects in migraine patients
Oct 25, 2021
tinniwell shows very good effects in migraine patients
Oct 25, 2021
Due to high demand, the 5th series of tinniwell will be produced earlier.
Jul 26, 2021
Due to high demand, the 5th series of tinniwell will be produced earlier.
Jul 26, 2021
Due to high demand, the 5th series of tinniwell will be produced earlier.
Jul 26, 2021
tinniwell 2.0 goes into production
May 6, 2021
tinniwell 2.0 goes into production
May 6, 2021
tinniwell 2.0 goes into production
May 6, 2021
New packaging for the tinniwell
Feb 8, 2021
New packaging for the tinniwell
Feb 8, 2021
New packaging for the tinniwell
Feb 8, 2021
Approval procedures changed at the FDA
Dec 16, 2020
Approval procedures changed at the FDA
Dec 16, 2020
Approval procedures changed at the FDA
Dec 16, 2020
The study on tinniwell is delayed due to COVID-19.
Nov 12, 2020
The study on tinniwell is delayed due to COVID-19.
Nov 12, 2020
The study on tinniwell is delayed due to COVID-19.
Nov 12, 2020
Production of the 4th series of tinniwell has started
Nov 10, 2020
Production of the 4th series of tinniwell has started
Nov 10, 2020
Production of the 4th series of tinniwell has started
Nov 10, 2020
Tinnitus: 4 phases to healing with Tailor-Made Notched Music Training (TMNMT) discovered with tinniwell
May 18, 2020
Tinnitus: 4 phases to healing with Tailor-Made Notched Music Training (TMNMT) discovered with tinniwell
May 18, 2020
Tinnitus: 4 phases to healing with Tailor-Made Notched Music Training (TMNMT) discovered with tinniwell
May 18, 2020
Work has started on the FDA approval of tinniwell
May 15, 2020
Work has started on the FDA approval of tinniwell
May 15, 2020
Work has started on the FDA approval of tinniwell
May 15, 2020
Resaphene Suisse AG announces the cancellation of the securitization of the shares
Apr 28, 2020
Resaphene Suisse AG announces the cancellation of the securitization of the shares
Apr 28, 2020
Resaphene Suisse AG announces the cancellation of the securitization of the shares
Apr 28, 2020
Resaphene Suisse AG has announced the withdrawal of its inclusion in the Vienna MTF at the Vienna Stock Exchange.
Mar 31, 2020
Resaphene Suisse AG has announced the withdrawal of its inclusion in the Vienna MTF at the Vienna Stock Exchange.
Mar 31, 2020
Resaphene Suisse AG has announced the withdrawal of its inclusion in the Vienna MTF at the Vienna Stock Exchange.
Mar 31, 2020
Ethics committee of Charité in Berlin approves study on tinnitus therapy tinniwell
Jan 21, 2020
Ethics committee of Charité in Berlin approves study on tinnitus therapy tinniwell
Jan 21, 2020
Ethics committee of Charité in Berlin approves study on tinnitus therapy tinniwell
Jan 21, 2020
Expansion to North America
Feb 20, 2019
Expansion to North America
Feb 20, 2019
Expansion to North America
Feb 20, 2019
Resaphene Suisse AG announces patent on tinniwell
Feb 4, 2019
Resaphene Suisse AG announces patent on tinniwell
Feb 4, 2019
Resaphene Suisse AG announces patent on tinniwell
Feb 4, 2019
Tinniwell receives patent in the USA
Dec 8, 2018
Tinniwell receives patent in the USA
Dec 8, 2018
Tinniwell receives patent in the USA
Dec 8, 2018
Tinniwell is covered by health insurance companies
Nov 8, 2018
Tinniwell is covered by health insurance companies
Nov 8, 2018
Tinniwell is covered by health insurance companies
Nov 8, 2018
Cooperation with GEHE Pharma Trade
Aug 4, 2018
Cooperation with GEHE Pharma Trade
Aug 4, 2018
Cooperation with GEHE Pharma Trade
Aug 4, 2018
Resaphene Suisse AG is going public
Jun 21, 2018
Resaphene Suisse AG is going public
Jun 21, 2018
Resaphene Suisse AG is going public
Jun 21, 2018
Test winner: tinniwell impresses in comparison test of tinnitus therapy systems
Feb 28, 2018
Test winner: tinniwell impresses in comparison test of tinnitus therapy systems
Feb 28, 2018
Test winner: tinniwell impresses in comparison test of tinnitus therapy systems
Feb 28, 2018
New state company at Resaphene
Jan 4, 2018
New state company at Resaphene
Jan 4, 2018
New state company at Resaphene
Jan 4, 2018
+41 71 510 07 24
Do you want to test our tinnitus therapy without obligation?
+41 71 510 07 24
